Novo Nordisk (NVO) Stock Price
$71.5 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
4 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Novo Nordisk, AI stock picks, stock alerts and much more.
NVO AI Stock Analysis
Financial Performance
Novo Nordisk has shown a steady increase in revenue, gross profit and operating income. The company's revenue was up by 4.8% from the previous quarter and up by 8.3% year over year. Gross profit also showed an increase of 3.8% from the previous quarter and up by 7.4% YoY, while their operating income had a significant boost of 30.4% QoQ and impressive growth of 26.4% YoY.
The EBITDA ratio of the last quarter was at a healthy level of .52 indicating that the company is generating positive cash flow.
Stock Price
The stock price, however, seems to be on a downward trend with -20.6% drop in the last month and -26.7% drop YoY, currently trading at $84.88 which is significantly below its 200-day moving average of $120.92. The RSI value stands at around mid-range (47), suggesting neither overbought nor oversold conditions.
Alternative Data Signals
The website traffic for Novo Nordisk has seen a decrease both MoM (-29%) and YoY (-20%). However, there is positive news as well; job postings have increased significantly YoY (+111%) indicating potential expansion or growth plans within the firm.
Around 86% employees reported having a positive business outlook towards Novo Nordisk despite it being slightly less than last year(-2%). Social media followers across various platforms such as Twitter(+3%), Instagram(+38%) & Facebook(+1%) have been growing steadily over past few months which could indicate increasing brand popularity and reach.
Conclusion
While Novo Nordisk's financial performance and employee outlook are strong, the stock price has been declining. Also, website traffic has decreased but social media following is on an upward trend. The analysis would be neutral to slightly bullish for Novo Nordisk's stock.
Note: This AI Stock Analysis is based on data as of January 31. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Novo Nordisk (NVO) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Novo Nordisk (NVO), currently trading at $71.5, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About NVO
-
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide.
-
Symbol
NVO
-
Market
NYSE
-
Industry
Biotechnology
-
Market Cap
315.4B
Similar Stocks
 |
Zymeworks ZYME |
$11.43 0.7% |
4 |
 |
Ginkgo Bioworks Holdings DNA |
$6.95 4.1% |
2 |
 |
Arcus Biosciences RCUS |
$8.93 6.1% |
5 |
News
NVO Alternative Data
Web Traffic
Novo Nordisk receives an estimated 701955 monthly visitors to novonordisk.com.
-
Web Traffic
701955
-
Change from Previous Month
14.6%
-
3 Month Change
12.1%
-
YoY Change
12.1%
Twitter Followers
Novo Nordisk has 50,892 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.4% over the last month.
-
Twitter Followers
50892
-
Daily Change
0%
-
1 Month Change
0.4%
-
3 Month Change
0.8%
-
YoY Change
0.8%
Facebook Engagement
Novo Nordisk has engaged 11,366 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
11366
-
Daily Change
2.1%
-
1 Month Change
65%
-
3 Month Change
2.7%
-
YoY Change
2.7%
Instagram Followers
Novo Nordisk has 143,408 Instagram Followers on its main Instagram account, up by 1% over the last month.
-
Instagram Followers
143408
-
Daily Change
0.1%
-
1 Month Change
1%
-
3 Month Change
4.7%
-
YoY Change
4.7%
Youtube Subscribers
Novo Nordisk has 41,100 subscribers on its main Youtube channel, up by 0.7% over the last month.
-
Youtube Subscribers
41100
-
Daily Change
0%
-
1 Month Change
0.7%
-
3 Month Change
1.7%
-
YoY Change
1.7%
Job Postings
Novo Nordisk has an estimated 844 open job postings, which is down -3.3% over the last month.
-
Job Postings
844
-
Daily Change
2.7%
-
1 Month Change
3.3%
-
3 Month Change
13.5%
-
YoY Change
13.5%
LinkedIn Employees
According to LinkedIn, Novo Nordisk has 66,442 employees, up by 0.9% over the last month.
-
LinkedIn Employees
66442
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
2.9%
-
YoY Change
2.9%
Reddit Mentions
Novo Nordisk has been mentioned an estimated 5 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
5
-
Daily Change
0%
-
1 Month Change
66.7%
-
3 Month Change
61.5%
Reddit Sentiment
The sentiment Score for Novo Nordisk is 52 out of 100, which represents a neutral sentiment.
-
Reddit Sentiment
52.1667
-
Daily Change
33%
-
1 Month Change
5.5%
Business Outlook
According to employee reviews, the business outlook among employees at Novo Nordisk is 84 out of 100 (very bullish), down by -1.2% over the last month.
-
Business Outlook
84
-
Change from Previous Month
1.2%
-
3 Month Change
3.4%
-
YoY Change
3.4%
LinkedIn Followers
2,310,547 are following Novo Nordisk on LinkedIn.
-
LinkedIn Followers
2310547
-
1 Month Change
0%
News Mentions
Novo Nordisk was mentioned 14 times in the news yesterday.
-
News Mentions
14
-
Daily Change
12.5%
-
1 Month Change
0%
-
3 Month Change
133.3%
NVO Financials
NVO Key Metrics
-
Total Revenue
DKK85.7B
-
Net Income
DKK28.2B
-
Earnings per Share
DKK6.34
-
Free cash flow
-DKK4.3B
-
EBITDA
DKK40.1B
-
EBITDA Ratio
0.468494
-
Total Assets
DKK465.8B
NVO 2-year Revenue & Income
NVO 2-year Free Cash Flow
NVO Technicals
NVO SMA
NVO RSI
FAQ
What's the current price of Novo Nordisk (NVO) Stock?
The price of an Novo Nordisk (NVO) share is $71.5.
What's the market cap of Novo Nordisk?
The current market cap of Novo Nordisk is 315.4B.
Should I buy or sell NVO?
Novo Nordisk shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Novo Nordisk is better viewed as a hold or accumulate position while waiting for further developments.
Is Novo Nordisk a good investment?
The current analysis of Novo Nordisk's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Novo Nordisk's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Novo Nordisk (NVO) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Novo Nordisk stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Novo Nordisk (NVO) that investors often compare it to?
Novo Nordisk (NVO) is often compared to similar stocks such as Zymeworks, Ginkgo Bioworks Holdings and Arcus Biosciences.
What is the forecast for Novo Nordisk's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Novo Nordisk's stock price to be around $73.33 in 2026. Starting from the current price of $71.5, this represents a 2.6% change in price, indicating a neutral outlook for the stock.
How to buy Novo Nordisk (NVO) Stock?
Novo Nordisk stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Novo Nordisk shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.